VentriPoint Diagnostics Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VPTDF research report →
About the company
VentriPoint Diagnostics Ltd. (VPTDF) is a medical technology company dedicated to creating and bringing to market diagnostic tools for the global assessment of patients with cardiac conditions. The company's primary offering is the VentriPoint Medical System (VMS), an advanced medical imaging platform.
- CEO
- Hugh MacNaught
- IPO
- 2010
- Employees
- 3
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $14.58M
- P/E
- -5.38
- P/S
- 109.51
- P/B
- -4.32
- EV/EBITDA
- -6.69
- Div Yield
- 0.00%
- Gross Margin
- 82.94%
- Op Margin
- -1889.37%
- Net Margin
- -1778.62%
- ROE
- 78.25%
- ROIC
- 222.24%
- Revenue
- $179.78K · 88.90%
- Net Income
- $-3,197,633 · 35.00%
- EPS
- $-0.02 · 37.94%
- Op Income
- $-3,396,732
- FCF YoY
- 54.12%
- 52W High
- $0.14
- 52W Low
- $0.06
- 50D MA
- $0.09
- 200D MA
- $0.08
- Beta
- 0.06
- Avg Volume
- 100.26K
Get TickerSpark's AI analysis on VPTDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our VPTDF coverage
Recent articles, reports, and earnings notes.
No research on VPTDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VPTDF report →Similar companies
Peers in the same neighborhood.